comparemela.com

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. During the quarter the strategy returned -6.0% net of fees compared to the S&P 500’s -3.3% return. As the quarter demonstrated, the markets are uncertain. In addition, you […]

Related Keywords

,Nasdaq ,Davis Fund ,Popular Stocks Among Hedge ,Patient Capital Management ,Ipac Inc ,Nvestor Letter ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.